Journal article

Clinical status and implications of antimalarial drug resistance.

Abstract:: Africa carries the greatest burden of disease caused by Plasmodium falciparum, and we can expect this burden to rise in the near future, mainly because of drug resistance. Although effective drugs are available (such as artemether-lumefantrine, mefloquine, atovaquone-proguanil and halofantrine) they are uniformly too expensive for routine use. Affordable options include chloroquine plus sulfadoxine-pyrimethamine (SP), amodiaquine (alone or in combination with SP) and chlorproguanil-dapsone. Artemisinin combination therapy may offer considerable advantages over alternative therapies, but its introduction faces considerable logistic difficulty.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Winstanley, P., Ward, S. A., & Snow, R. (2002). Clinical status and implications of antimalarial drug resistance. Microbes and Infection / Institut Pasteur, 4(2), 157–164.

MLA Style

Winstanley, P, et al. “Clinical Status and Implications of Antimalarial Drug Resistance.” Microbes and Infection / Institut Pasteur, vol. 4, no. 2, 2002, pp. 157–64.

Chicago Style

Winstanley, P, SA Ward, and R Snow. 2002. “Clinical Status and Implications of Antimalarial Drug Resistance.” Microbes and Infection / Institut Pasteur 4 (2): 157–64.
Print

Access Document

Publisher copy:: 10.1016/s1286-4579(01)01523-4

Authors

+ Winstanley, P More by this author

Role:: Author

+ Ward, SA More by this author

Role:: Author

+ Snow, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: Tropical Medicine
Role:: Author

Journal:: Microbes and infection / Institut Pasteur More from this journal
Volume:: 4
Issue:: 2
Pages:: 157-164
Publication date:: 2002-02-01
DOI:: 10.1016/s1286-4579(01)01523-4
EISSN:: 1769-714X
ISSN:: 1286-4579

Language:: English
Keywords:: Plasmodium falciparum

National Health Programs

Humans

World Health Organization

Malaria

Culicidae

Antimalarials

Drug Resistance

Disease Vectors

Animals

Health Policy

Africa
Pubs id:: pubs:38153
UUID:: uuid:02ff3937-34d9-400a-aae0-73f84358fab2
Local pid:: pubs:38153
Source identifiers:: 38153
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_02ff393734d9400aaae073f84358fab2

Terms of use

Copyright date:: 2002

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP